Our proprietary algorithms analyze molecular biomarkers and genomic sequencing to deliver individualized treatment recommendations with unprecedented accuracy.
Physicians are empowered with actionable precision decision support to optimize outcomes for each unique patient.
Prognose over many cancer types from liquid biopsies
Predict responses to emerging targeted therapies
Through large-scale analytics, we have implemented biomarkers associated with resistance and progression into our model.
Our algorithms track tumors' molecular evolution during therapy to inform maintenance approaches.
Partnering with healthcare systems expands our platform's training on unselected patient populations.
Physicians utilize our treatment recommendations and reporting to optimize precision therapies
We collaborate with leading research institutions to generate novel hypotheses on biomarkers, combinations, and resistant mechanisms. Pharmaceutical partners leverage our analytics to accelerate trial design and real-world evaluation of pipelines.
"Oncolytic's platform has revolutionized how I determine the best treatment plan for patients. The accurate recommendations save weeks of trial and error and improve clinical outcomes."
"I have had the privilege of working closely with on multiple projects, and I can confidently say they are a true expert in their field. Their dedication, attention to detail, and problem-solving skills have been instrumental in achieving successful outcomes."
"I recently completed a course with and it exceeded my expectations. The course material was comprehensive, the instructors were highly knowledgeable, and the interactive learning environment made the experience enjoyable."
"I have had the privilege of working closely with on multiple projects, and I can confidently say they are a true expert in their field. Their dedication, attention to detail, and problem-solving skills have been instrumental in achieving successful outcomes."
